Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024

  1. PureTech Health plc

    World Rank (Jan-05-2024)
    10,326
    Market Cap (Jan-05-2024)
    0.728 Billion USD
    World Rank (Jul-30-2023)
    9,828
    Market Cap (Jul-30-2023)
    0.812 Billion USD
    World Rank (Dec-25-2022)
    8,847
    Market Cap (Dec-25-2022)
    0.913 Billion USD
    World Rank (Jan-07-2022)
    8,692
    Market Cap (Jan-07-2022)
    1.15 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -197 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    PureTech Health is a Biotechnology company. The headquarters is in USA.
  2. RAPT Therapeutics Inc.

    World Rank (Jan-05-2024)
    9,736
    Market Cap (Jan-05-2024)
    0.807 Billion USD
    World Rank (Jul-30-2023)
    9,835
    Market Cap (Jul-30-2023)
    0.812 Billion USD
    World Rank (Dec-25-2022)
    11,440
    Market Cap (Dec-25-2022)
    0.583 Billion USD
    World Rank (Jan-07-2022)
    8,681
    Market Cap (Jan-07-2022)
    1.16 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -85 Million USD
    Annual Net Income in USD
    -84 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    RAPT Therapeutics is a Clinical Stage Immunology Based Biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. It is having 68 employees as on 2019. The headquarters is in USA.
  3. Scilex Holding Company

    World Rank (Jan-05-2024)
    17,962
    Market Cap (Jan-05-2024)
    0.198 Billion USD
    World Rank (Jul-30-2023)
    9,933
    Market Cap (Jul-30-2023)
    0.800 Billion USD
    World Rank (Dec-25-2022)
    12,761
    Market Cap (Dec-25-2022)
    0.474 Billion USD
    Headquarters Country
  4. Collegium Pharmaceutical

    World Rank (Jan-05-2024)
    8,100
    Market Cap (Jan-05-2024)
    1.103 Billion USD
    World Rank (Jul-30-2023)
    10,025
    Market Cap (Jul-30-2023)
    0.785 Billion USD
    World Rank (Dec-25-2022)
    9,777
    Market Cap (Dec-25-2022)
    0.771 Billion USD
    World Rank (Jan-07-2022)
    11,744
    Market Cap (Jan-07-2022)
    0.66 Billion USD
    Annual Revenue in USD
    463 Million USD
    Annual Operating Income in USD
    33 Million USD
    Annual Net Income in USD
    -25 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Collegium Pharmaceutical is a Specialty Pharmaceutical company committed to being the leader in responsible pain management. It has been focused on developing and commercializing new medicines for pain management that reflect its core values and commitment to people suffering from pain, providers and communities. The headquarters is in USA.

  5. Viridian Therapeutics Inc.

    World Rank (Jan-05-2024)
    7,887
    Market Cap (Jan-05-2024)
    1.157 Billion USD
    World Rank (Jul-30-2023)
    10,091
    Market Cap (Jul-30-2023)
    0.775 Billion USD
    World Rank (Dec-25-2022)
    7,533
    Market Cap (Dec-25-2022)
    1.200 Billion USD
    World Rank (Jan-07-2022)
    14,511
    Market Cap (Jan-07-2022)
    0.43 Billion USD
    Headquarters Country
  6. 4D Molecular Therapeutics Inc.

    World Rank (Jan-05-2024)
    9,373
    Market Cap (Jan-05-2024)
    0.862 Billion USD
    World Rank (Jul-30-2023)
    10,151
    Market Cap (Jul-30-2023)
    0.768 Billion USD
    World Rank (Dec-25-2022)
    10,358
    Market Cap (Dec-25-2022)
    0.699 Billion USD
    World Rank (Jan-07-2022)
    12,298
    Market Cap (Jan-07-2022)
    0.60 Billion USD
    Annual Revenue in USD
    3 Million USD
    Annual Operating Income in USD
    -110 Million USD
    Annual Net Income in USD
    -107 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    4D Molecular Therapeutics is an Innovative Gene Therapy company designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company annual revenue is 6.99 million USD and 78 employees as on 2019. The headquarters is in USA.
  7. Centessa Pharmaceuticals PLC

    World Rank (Jan-05-2024)
    10,928
    Market Cap (Jan-05-2024)
    0.657 Billion USD
    World Rank (Jul-30-2023)
    10,198
    Market Cap (Jul-30-2023)
    0.762 Billion USD
    World Rank (Dec-25-2022)
    15,498
    Market Cap (Dec-25-2022)
    0.310 Billion USD
    World Rank (Jan-07-2022)
    10,634
    Market Cap (Jan-07-2022)
    0.80 Billion USD
    Headquarters Country
  8. Vera Therapeutics Inc.

    World Rank (Jan-05-2024)
    10,674
    Market Cap (Jan-05-2024)
    0.689 Billion USD
    World Rank (Jul-30-2023)
    10,207
    Market Cap (Jul-30-2023)
    0.761 Billion USD
    World Rank (Dec-25-2022)
    11,799
    Market Cap (Dec-25-2022)
    0.550 Billion USD
    World Rank (Jan-07-2022)
    14,196
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Headquarters Country
  9. Biomea Fusion Inc.

    World Rank (Jan-05-2024)
    12,072
    Market Cap (Jan-05-2024)
    0.546 Billion USD
    World Rank (Jul-30-2023)
    10,266
    Market Cap (Jul-30-2023)
    0.753 Billion USD
    World Rank (Dec-25-2022)
    17,307
    Market Cap (Dec-25-2022)
    0.228 Billion USD
    World Rank (Jan-07-2022)
    18,155
    Market Cap (Jan-07-2022)
    0.23 Billion USD
    Headquarters Country
  10. Kura Oncology

    World Rank (Jan-05-2024)
    7,868
    Market Cap (Jan-05-2024)
    1.161 Billion USD
    World Rank (Jul-30-2023)
    10,368
    Market Cap (Jul-30-2023)
    0.739 Billion USD
    World Rank (Dec-25-2022)
    9,716
    Market Cap (Dec-25-2022)
    0.781 Billion USD
    World Rank (Jan-07-2022)
    10,231
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -139 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Kura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.

Share

Ads